|
decisions apply in RACFs as they do
in the community ; consciously resist the institutional model of care , paternalism , ageism and patient disempowerment . Ask the service for families , where wanted by the patient or where required for consent , to be involved in discussion at the time of consultation
|
dakaufman123 / bit . ly / 3DQHd36 |
pain ?” with a “ No ”, or “ I don ’ t know ”, then deprescribe this medication . If the pain does not clearly recur or worsen on deprescribing , this is further evidence the medication was not helpful . Pain that improves while a person is on medication is not evidence that the medication has caused |
||||||
either on the phone or in person , as you |
the improvement . This false assump- |
|||||||
would in your office . |
tion may lead to patient reluctance to |
|||||||
|
MINDFUL REPRESCRIBING – A PRACTICAL APPROACH
IF all prescribed medications were
intended to continue indefinitely there
|
deprescribe and can often be resolved with discussion . Many chronic or acute pain issues self-resolve , are self-limiting or episodic . 22
Is it causing harm ?
Responsible prescribing outlines pos-
|
|||||||
would be little need for repeat pre- |
sible side effects , interactions , phys- |
|||||||
scriptions from a doctor . The purpose |
iological and functional impacts . |
|||||||
of represcribing is to check that the |
Enquiring about their presence will |
|||||||
medication is still indicated , is still the |
prompt discussion about the risk – |
|||||||
best option for the condition and the |
benefit balance in individual patients |
|||||||
patient , to check that it is having the |
and may guide deprescribing . Always |
|||||||
desired effect , to assess for side effects |
consider whether a new symptom |
|||||||
or interactions , to confirm the dose is |
or problem is medication related . |
|||||||
still appropriate and , importantly , to |
Treatment then may be deprescrib- |
|||||||
check it is still wanted by the patient . |
ing rather than adding a new product , |
|||||||
These checks ( see box 4 ) will |
thus avoiding a prescribing cascade . |
|||||||
become quick and automatic once |
Single medications can have trou- |
|||||||
incorporated into the represcribing |
blesome side effects in some patients ; |
|||||||
thought process ; apply each time a |
this is compounded and far more |
|||||||
prescription is rewritten or a medica- |
common in polypharmacy , multiple |
|||||||
tion chart is rolled over . Failing to con- |
morbidities and the frail elderly . |
|||||||
sider these issues amounts to mindless |
The potentiation of pharmaco- |
|||||||
rollover and makes it very difficult |
logical effects and compounding of |
|||||||
to routinely consider deprescribing . |
side effects can be hard to recognise , |
|||||||
These factors , when presented to the |
especially in those who are unable to |
|||||||
patient , also form the fundamental |
communicate easily or who have cog- |
|||||||
|
components of informed consent .
Indication
Understanding the indication may
|
nitive impairment . This is the group most vulnerable to insufficient attention to medication-related harm , and who may benefit greatly from |
|||||||
expose unsatisfactory reasons for con- |
thoughtful deprescribing . |
|||||||
tinuation of a medication . Depend- |
There are tools available , such |
|||||||
ence and fear of withdrawal are very |
as the drug burden index , to look at |
|||||||
real issues in patients taking drugs of |
anticholinergic burden . 24 |
|||||||
addiction ; this may need long engage- |
Anticholinergic side effects include |
|||||||
ment or expert assistance and advice and significant support . If it is clear |
Figure 6 . Medication list for a bed-bound nursing home patient . |
constipation , confusion and hallucination , memory disturbance , dry |
||||||
|
the indication for a drug of addiction is one that is family driven rather than patient driven , then this needs caution and definite addressing . For example , a family member insists that a patient needs ongoing opiates , including patches , or benzodiazepines in the absence of any symptoms that would warrant their use , and there are grounds to suspect this medication is being abused by others or diverted onto the black market .
Present the absence of an indication as a positive outcome for patients ; they have recovered or no longer need that medication . If patients are resistant to deprescribing , point out that the medication is not providing a benefit , may
|
Box 4 . Mindful represcribing
• Is the indication still clear and applicable ?
• Is this medication the best option ? — Consider non-pharmacological alternatives , newer medications , more targeted or specific , easier schedules or regimes .
• Is it actually working ?
• Is it causing harm ? — Check interactions , blood tests and side-effect symptoms and signs .
• Is the dose / regimen appropriate or can it be reduced ( either the dose or frequency )? — Same effect at a lower dose , trial of deprescribing .
• Does the patient still want it ? — Are they consenting , considering all the factors in the decision , or merely agreeing ? — Are they trying to please you ? — Have their goals changed ?
|
Is it working ?
When a medication is initiated for a
particular indication , it is fundamental to expect a benefit from that medication . If that expected benefit does not occur , it is important that this is recognised early , and the medication stopped . If medication is still thought to be indicated , then try an alternative . If a medication is not working , it is easy to add another drug ; however , it is usually better to substitute another drug for it . This is deprescribing one medication to prescribe another . It allows the second drug the opportunity to be evaluated alone and prevents the risk of compounding any adverse effects .
|
mouth and eyes , falls , urinary retention and drowsiness / sedation . These may all be incorrectly attributed to ‘ old age ’. Impacts of sedation in the elderly include reduced oral intake with malnutrition and dehydration , falls , physical deconditioning with loss of independent function , pressure injury , reduced ability to interact meaningfully with loved ones or carers and reduced ability to participate in pleasurable activity ( see figure 7 ). 25 The sensitivity of the frail and cognitively impaired elderly patient makes these impacts particularly marked . The reduction of quality of life can be profound , and deprescribing can make a real and satisfying improvement . |
|||||
be causing harm and should not be |
A drug that is not working is generally |
Many individual agents are costly , |
||||||
used . Sometimes the practitioner may |
not required and should not be used . |
and polypharmacy can be expensive . |
||||||
need to explain they can no longer ethically prescribe a medication that cannot be justified , has no rationale and no |
chronic pain , anxiety , depression , insomnia and constipation . 16 This is an opportunity to review treatable causes |
Other drugs occasionally encountered are barbiturates for epilepsy or older beta blockers such as propran- |
If a drug is used to treat a condition that can be monitored , for example blood pressure or blood markers , |
The financial burden is rarely considered and may be a significant additional incentive to deprescribing . |
|
potential for benefit . Patients cannot compel a doctor to prescribe .
Medications intended to be tempo-
|
of the condition and assess whether the current approach is still the best option . Routine represcribing can lead |
olol for hypertension or cardiac rate control , which can be updated to a more cardio-specific medication such |
these may be used as an indication that the medication is of benefit . If a drug is being used only for symptom |
Dose / regimen
Reducing the dose or frequency of
|
rary that may be continued indefinitely |
to prolonged use of drugs that are no |
as metoprolol , with a better side-effect |
management and the patient does not |
a drug is a form of deprescribing . In |
include anticoagulation after DVT , cor- |
longer the best option for the condi- |
profile . Older antipsychotics such as |
think it has helped , there is no bene- |
general , prescribe the lowest effective |
ticosteroids for acute pulmonary and |
tion , if indeed the condition still exists . |
chlorpromazine have modern alterna- |
fit to be gained and the drug should be |
dose ; if this dose is effective , reduc- |
dermatological conditions , sedatives |
For example , a patient with chronic |
tives with much fewer adverse effects . |
stopped . |
ing the risk of side effects is achieved . |
( for example , antipsychotics or benzo- |
dizziness who has been treated for a |
Prednisone has a significant |
Non-opiate medication , such as |
Changes in body weight or change in |
diazepines ) to manage transient behav- |
long time with prochlorperazine is still |
adverse effect profile , particularly |
gabapentinoids ( pregabalin and gab- |
the patient condition / s and the pres- |
iour concerns or acute postoperative or |
unsteady and falling . This suggests the |
with prolonged use . It is impor- |
apentin ) or anticonvulsants ( val- |
ence of possible side effects should |
ICU care and analgesics for acute pain . |
medication is not working . A review |
tant to understand the condition |
proate ) are commonly used to treat |
trigger a review of the dose . |
|
Best option
Once the indication for use of a medication
has been clearly established , consider if medication is the best way
|
of the dizziness indicates there may be a component of vertigo present and a specialist referral is made . Testing confirms benign paroxysmal positional vertigo and an Epley manoeuvre |
that is being treated and consider newer disease-modifying agents , for example in rheumatoid arthritis , or whether the agent was intended for short-term use , such as post-exacer- |
pain . There is , however , very limited evidence for efficacy in chronic pain , even when there is associated neuropathy . 22 There is increasing recognition of the impact of adverse effects |
Patients usually welcome a simplified medication regimen . Remembering to take medication can be problematic and burdensome . It is easier to take all medications at |
to manage this condition . Many people are open to suggestions of non-phar- |
is successfully performed . The patient has stopped falling and no longer |
bation COPD , or whether review and tapering was intended , as in polymy- |
of these medications 23 If a patient responds to the ques- |
one time of day rather than several times a day , and when a carer |
macological alternatives to manage |
requests medication . |
algia rheumatica . |
tion : “ Has the pregabalin helped your |
administers medication . |